Disease modification and progression in pre–chronic obstructive pulmonary disease: an official American Thoracic Society workshop report
- 11 February 2026
- journal article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (5) , 667-688
Abstract
Chronic obstructive pulmonary disease (COPD) is a highly prevalent and burdensome disease that develops over decades. Treatments for COPD are most commonly prescribed in later stages of the disease, leaving missed opportunities to modify the course of disease at earlier stages. This workshop was conducted to promote progress in the design and conduct of clinical trials of treatments that modify progression to COPD. The aims of the workshop were to provide an operational definition of pre-COPD and to discuss the elements and design of potential clinical trials in pre-COPD. The key focus areas of this workshop included: (1) defining a study population for pre-COPD clinical trials; (2) endpoints in pre-COPD clinical trials; and (3) design considerations for pre-COPD clinical trials.Keywords
Funding Information
- American Thoracic Society
This publication has 156 references indexed in Scilit:
- Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary DiseaseJAMA, 2025
- Making Pragmatic Clinical Trials More PragmaticJAMA, 2024
- Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care SettingsJAMA, 2023
- Sequential, Multiple Assignment, Randomized Trial DesignsJAMA, 2023
- Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US AdultsJAMA, 2021
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19JAMA, 2020
- Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older AdultsJAMA, 2020
- Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in AdultsJAMA Internal Medicine, 2020
- Assessment of Pragmatism in Recently Published Randomized Clinical TrialsJAMA Internal Medicine, 2018
- The Platform TrialJAMA, 2015